Top Markets
Coin of the day
Lushang Freda Pharmaceutical Co.,Ltd. Lushang Freda Pharmaceutical Co.,Ltd.

Lushang Freda Pharmaceutical Co.,Ltd.

600223
Kedudukan dalam Saham #10388
Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development,... Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.
Harga Saham
$0.83325484
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$847.06M
Perubahan (1 hari)
0.70%
Perubahan (1 tahun)
-26.10%
Negara
CN
Perdagangan Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Kategori

EPS untuk Lushang Freda Pharmaceutical Co.,Ltd. (600223)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham Lushang Freda Pharmaceutical Co.,Ltd., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk Lushang Freda Pharmaceutical Co.,Ltd. dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa